Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
